Put down the 10-K filings and the stock screeners. It’s time to take a break from the traditional methods of generating investment ideas. Instead, let the crowd do it for you.From hedge funds to individual investors, scores of market participants are turning to social media to figure out which stocks are worth watching. It’s a concept that’s known as “crowdsourcing,” […]
Biotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months. And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For perspective, the S&P 500 only boasts 41% on that front, and […]
Putin biographer: He’s not dead — but chaos is brewing in the Kremlin by BusinessInsider.com : Friday 02:45:00 CTCategories: markets, streamThere’s something going on behind the scenes in the Kremlin.Russian president Vladimir Putin hasn’t been seen in public since March 5. (Video featuring Putin on March 13 was not live.)Analysts are speculating that his absence suggests there may be a […]
More Charts
Remember when Federal Reserve Chair Janet Yellen said that social media and biotech stocks seemed pricey during a July 2014 testimony to Congress? “…Valuation metrics in some sectors do appear substantially stretched—particularly those for smaller firms in the social media and biotechnology industries, despite a notable downturn in equity prices for such firms early in the year,” she said.On Twitter, […]
View photo.Short interest among leading biotechs and emerging pharmaceuticals increased nearly all across the board between February 13 and February 27.Leading the trend were BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Celgene Corporation (NASDAQ: CELG) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).Here, Benzinga takes a quick look at how the stocks have fared recently and what analysts expects from them, followed by a […]
View All3 Biotech Stocks That Could Pop in a HeartbeatBiotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months.Click to Enlarge And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For […]
Dear Reader,I still expect US stock markets to fall 20% in 2015 from the current levels measured by the main indices. US tech stocks and biotech stocks are in a bubble and should fall more than 30% from the current levels. Eurozone stocks should fall 20% from the current levels.US treasuries should sell off in 2015. The 10 year yield […]
Gold Up 11% in Euro This Year As Currency Wars IntensifyGold has risen 11% versus the euro in 2015
Builds on 12% gains against the euro in 2014
Sentiment poor despite reasonable performance
Gold performing well considering significant gains in stocks and dollar
Dollar centric view misleading
Currency wars intensifying
Complacency and hubris rife
Gold rose 12% against the euro in 2014 and so far in 2015, […]
Art by Mike LucasAllergen Research has raised $80 million to help tackle the problem of peanut allergies, Brian Gormley reports for Dow Jones VentureWire. The company is developing a product that desensitizes patients so that accidental exposure to peanuts doesn’t cause a severe allergic response. Peanut allergy is one of the most common of food allergies, which affect 5% of children and 4% […]
The bull market turned six-years-old this week, which is pretty amazing. It’s been quite a ride. In that time, the Dow Jones Industrial Average has charged ahead more than 150%, the S&P 500 180% and Nasdaq 250%. One group that has been at the forefront of this bull market is biotech stocks.Source: FlickrIn fact, the past five years have been […]
